Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae
Authors
Keywords
-
Journal
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 36, Issue 08, Pages 981-985
Publisher
Cambridge University Press (CUP)
Online
2015-05-20
DOI
10.1017/ice.2015.101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Renal Function on the Pharmacokinetics and Safety of Ceftolozane-Tazobactam
- (2014) Myra Wooley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli
- (2013) Pilar Retamar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications
- (2013) L. Lopez-Cerero et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
- (2012) Vicki L. Collins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli
- (2012) Teena Chopra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States
- (2012) Yohei Doi et al. CLINICAL INFECTIOUS DISEASES
- Extended-Spectrum β-Lactamase Producers Reported as Susceptible to Piperacillin-Tazobactam, Cefepime, and Cefuroxime in the Era of Lowered Breakpoints and No Confirmatory Tests
- (2012) Dror Marchaim et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
- (2012) K. Z. Vardakas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
- (2011) J. Rodriguez-Bano et al. CLINICAL INFECTIOUS DISEASES
- Can We Really Use ss-Lactam/ss-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ss-Lactamase-Producing Bacteria?
- (2011) F. Perez et al. CLINICAL INFECTIOUS DISEASES
- The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study
- (2011) Yehuda Carmeli et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by Enterobacteriaceae Producing Extended-Spectrum -Lactamases
- (2010) D. Marchaim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Hospital-Acquired Infections Due to Gram-Negative Bacteria
- (2010) Anton Y. Peleg et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients
- (2009) Ronen Ben‐Ami et al. CLINICAL INFECTIOUS DISEASES
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
- (2009) R Phillip Dellinger et al. CRITICAL CARE MEDICINE
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
- (2008) Teresa C. Horan et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Extended-spectrum β-lactamases in North America, 1987–2006
- (2008) K. Bush CLINICAL MICROBIOLOGY AND INFECTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now